Application segmentation dissects the lunasin market according to end‑use categories, providing a quantitative basis for revenue attribution. Dietary supplements represent the largest slice, accounting for roughly 40 % of total sales, driven by consumer demand for protein‑derived bioactives that support muscle maintenance and cardiovascular health. Functional foods contribute about 30 % as manufacturers embed lunasin in fortified beverages, snack bars, and dairy alternatives to leverage its anti‑inflammatory properties. The cosmetics segment, with an estimated 20 % share, exploits lunasin’s collagen‑preserving activity in anti‑aging creams and serums, aligning with the growing clean‑beauty trend. Finally, pharmaceutical applications, though nascent, occupy around 10 % of the market, focusing on clinical‑grade lunasin for investigational therapies targeting autoimmune disorders. Collectively, these application categories define the overall lunasin market size and are the sole basis for the accompanying pie‑chart, illustrating the relative weight of each segment within the current market taxonomy. These proportions are derived from compiled sales data across North America, Europe, and Asia‑Pacific, reflecting regional adoption patterns.
